stocks index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest abreakingelon musk details tesla model  pricing range atesla standard model  will cost  longrange model will cost  pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  incyte corporation  product pipeline review    compare about us  contact us home research category publisher list custom research cart compare research category user guide policies contact us about us site map home  market research report  pharmaceutical  pharmaceutical companies  pharma info market research report incyte corporation  product pipeline review   published by global markets direct product code  published may   content info  pages price usd  pdf by email single user license usd  pdf by email site license usd  pdf by email global license incyte corporation  product pipeline review   published may   content info  pages description summary global markets directs incyte corporation  product pipeline review   provides an overview of the incyte corporations pharmaceutical research and development focus the report provides comprehensive information on the therapeutics under development by incyte corporation complete with analysis by stage of development drug target mechanism of action moa route of administration roa and molecule type the report also covers the descriptive pharmacological action of the therapeutics its complete research and development history and the dormant and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites clinical trial registries conferences sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information additionally various dynamic tracking processes ensure that the most recent developments are captured on a real time basis the report helps in identifying and tracking emerging players in the market and their portfolios enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage note certain sections in the report may be removed or altered based on the availability and relevance of data scope the report provides a snapshot of the pipeline therapeutic landscape of incyte corporation the report provides overview of incyte corporation including its business description key facts and locations and subsidiaries the report features descriptive drug profiles for the pipeline products which includes product description descriptive moa rd brief licensing and collaboration details  other developmental activities the report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages the report assesses incyte corporations pipeline therapeutics based on drug target mechanism of action moa route of administration roa and molecule type the report features incyte corporations outlicensed and partnered product portfolio and summarizes its dormant and discontinued projects reasons to buy evaluate incyte corporations strategic position with total access to detailed information on its product pipeline gain strategically significant competitor information analysis and insights to formulate effective rd strategies identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage identify and understand important and diverse types of therapeutics under development for incyte corporation identify potential new clients or partners in the target demographic plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics devise corrective measures for pipeline projects by understanding incyte corporations pipeline depth and focus of pipeline therapeutics develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope table of contents product code gmdhccdbtable of contents table of contents list of tables list of figures incyte corporation snapshot incyte corporation overview key information key facts incyte corporation  research and development overview key therapeutic areas incyte corporation  pipeline review pipeline products by stage of development pipeline products  monotherapy pipeline products  combination treatment modalities pipeline products  partnered products partnered productscombination treatment modalities pipeline products  outlicensed products outlicensed productscombination treatment modalities incyte corporation  pipeline products glance incyte corporation  clinical stage pipeline products phase ii productscombination treatment modalities phase i productscombination treatment modalities incyte corporation  early stage pipeline products indcta filed productscombination treatment modalities preclinical productscombination treatment modalities discovery productscombination treatment modalities incyte corporation  drug profiles incb  incb product description mechanism of action rd progress epacadostat product description mechanism of action rd progress incb product description mechanism of action rd progress itacitinib adipate product description mechanism of action rd progress ruxolitinib phosphate product description mechanism of action rd progress incb product description mechanism of action rd progress incb product description mechanism of action rd progress incb product description mechanism of action rd progress incb product description mechanism of action rd progress incb product description mechanism of action rd progress incb product description mechanism of action rd progress shr product description mechanism of action rd progress incagn product description mechanism of action rd progress incagn product description mechanism of action rd progress incb product description mechanism of action rd progress monoclonal antibody to inhibit lag for oncology product description mechanism of action rd progress monoclonal antibody to inhibit tim for oncology product description mechanism of action rd progress small molecule for oncology product description mechanism of action rd progress small molecules for chronic inflammation product description mechanism of action rd progress incyte corporation  pipeline analysis incyte corporation  pipeline products by target incyte corporation  pipeline products by route of administration incyte corporation  pipeline products by molecule type incyte corporation  pipeline products by mechanism of action incyte corporation  recent pipeline updates incyte corporation  dormant projects incyte corporation  discontinued pipeline products discontinued pipeline product profiles aderbasib incb itacitinib adipate ruxolitinib phosphate incyte corporation  company statement incyte corporation  locations and subsidiaries head office other locations  subsidiaries appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tables incyte corporation key information incyte corporation key facts incyte corporation  pipeline by indication  incyte corporation  pipeline by stage of development  incyte corporation  monotherapy products in pipeline  incyte corporation  combination treatment modalities in pipeline  incyte corporation  partnered products in pipeline  incyte corporation  partnered products combination treatment modalities  incyte corporation  outlicensed products in pipeline  incyte corporation  outlicensed products combination treatment modalities  incyte corporation  phase ii  incyte corporation  phase i  incyte corporation  indcta filed  incyte corporation  preclinical  incyte corporation  discovery  incyte corporation  pipeline by target  incyte corporation  pipeline by route of administration  incyte corporation  pipeline by molecule type  incyte corporation  pipeline products by mechanism of action  incyte corporation  recent pipeline updates  incyte corporation  dormant developmental projects incyte corporation  discontinued pipeline products  incyte corporation subsidiaries list of figures incyte corporation  pipeline by top  indication  incyte corporation  pipeline by stage of development  incyte corporation  monotherapy products in pipeline  incyte corporation  combination treatment modalities in pipeline  incyte corporation  partnered products in pipeline  incyte corporation  outlicensed products in pipeline  incyte corporation  pipeline by top  target  incyte corporation  pipeline by route of administration  incyte corporation  pipeline by molecule type  incyte corporation  pipeline products by top  mechanism of action  phone intl  tollfreeus  europe  asia  new for   gii now purchases any market research reports from any publishers for you with noextra cost contact us for more details faq delivery time user license payment options compare multiple reports about contact user guide policies site map  copyright  global information inc all rights reserved incy stock price  incyte corp stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  col  lyb  fls  mo  sbux  gt  latest newsall times eastern a breaking elon musk details tesla model  pricing range a tesla standard model  will cost  longrange model will cost   updated wall street isn’t ready for a point tumble in the dow industrials  barrons buzz robo  facebook and twitter trading on news  a wild week in washington  updated the dark side of cruises  trump to police dont be too nice  updated the highest paid athletes in the world in one chart  updated oj simpson made over  while in prison and won’t have to give any of it to the goldman family  updated here are  coworkers you should avoid like the plague — especially in meetings to be replaced home investing quotes stocks united states incy overview compare quotes stock screener earnings calendar sectors nasdaq incy us nasdaq join td ameritrade find a broker incyte corp watchlist createincyalert after hours last updated jul    pm edt delayed quote     after hours volume k close chg chg     advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  m open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap b shares outstanding m public float m beta  rev per employee m pe ratio na eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume m performance  day   month   month  ytd   year  recent news marketwatch other dow jones eli lilly beats profit and sales expectations nda for ra treatment to be delayed eli lilly  co reported a secondquarter net profit that rose to  billion or  cents a share from  million or  cents a share in the same period a year ago excluding nonrecurring items adjusted eps was  beating the factset consensus of  revenue rose  to  billion above the factset consensus of  billion as strong growth in new pharmaceutical products helped offset weakness in animal health for  the drug giant expects adjusted eps of  to  surrounding the factset consensus of  while the revenue outlook was raised to  billion to  billion from  billion to  billion separately lilly and incyte corp said a resubmission for the new drug application for a treatment of rheumatoid arthritis will be delayed beyond  as the fda has indicated a new clinical study is necessary lillys stock was indicated slightly lower in premarket trade while incytes stock tumbled  year to date lilly shares have rallied  while the sp  has gained  jul   at  am et by tomi kilgore healthcare fund manager with  gain this year sees good times ahead as fda becomes ‘more accommodating’ jul   at  am et by philip van doorn scared of tech stocks healthcare shares are cheaper — and rallying jul   at  am et by philip van doorn wall street really hates giving any stock a ‘sell’ rating jun   at  am et by philip van doorn five reasons you have to buy biotech stocks now jun   at  pm et by michael brush three mustown cancer stocks for your biotechnology portfolio jun   at  pm et by michael brush cancer drug prices could double or triple thanks to this popular but unproven drug trend jun   at  pm et by emma court  big winners in the sp  this earnings season may   at  am et by philip van doorn stocks close higher as tech economic data power rebound may   at  pm et by barbara kollmeyer opinion what to do when your biotechnology stock gets hit by takeover rumors may   at  pm et by michael brush eli lilly beat profit views but cut outlook apr   at  am et stock market ends session slide as bank shares rally apr   at  pm et by wallace witkowski incyte stock price target cut to  from  at instinet apr   at  am et by tomi kilgore incyte stock price target cut to  from  at bmo capital apr   at  am et by tomi kilgore eli lilly and incyte stock drops after fda fails to approve rheumatoid arthritis drug apr   at  am et by emma court eli lilly stock drops  after fda failed to approve rheumatoid arthritis drug apr   at  am et by emma court incyte corp stock drops  after fda failed to approve rheumatoid arthritis drug apr   at  am et by emma court eli lilly and incyte fda letter says fda is unable to approve nda application in current form apr   at  am et by tomi kilgore eli lilly incyte receive complete response letter from fda apr   at  am et by tomi kilgore newlink genetics corp stock drops  on midstage results for melanoma drug apr   at  am et by emma court us stocks slide as oil slump hits energy sector us stock indexes retreated as oil prices slipped to their lowest levels since september pressuring the shares of energy companies jun   at  pm et on the wall street journal did gilead cut buybacks for acquisition gilead’s stock repurchases in the first quarter were half of the fourth quarter’s it may be eying incyte or biomarin may   at  am et on barrons online eli lilly working to cut costs apr   at  am et on the wall street journal stocks to watch moneygram eli lilly incyte apr   at  am et on the wall street journal fda rejects eli lilly and incyte rheumatoidarthritis drug apr   at  pm et on the wall street journal surprise fda rejection will sting this biotech apr   at  pm et on the wall street journal incyte why this biotech beauty can stay hot apr   at  pm et on barrons your cancer drugs may soon be discovered in china apr   at  am et on the wall street journal tech stocks that sit in the sweet spot mar   at  pm et on barrons race tightens for next wave of cancer drugs mar   at  am et on the wall street journal biotech executives sign letter against immigration order feb   at  pm et on the wall street journal more volatility ahead for biotechnology sector feb   at  pm et on the wall street journal drug pricing may linger over biotech in  jan   at  pm et on barrons smaller biotech buyout targets after medivation aug   at  am et on barrons incyte a biotech acquisition target jul   at  am et on barrons biotech labs birth new drugs—and new fortunes jun   at  pm et on the wall street journal bristolmyers to buy autoimmune disease treatment developer padlock mar   at  am et on the wall street journal agenus stock could surge to  mar   at  am et on barrons gilead way oversold as investors flee biotech feb   at  am et on barrons incyte reports profit but scraps trials involving cancer drug feb   at  am et on the wall street journal recent news other news press releases  things in biotech you should learn today july    things in biotech you should learn today july   jul   at  am et on seeking alpha gilead the greyhound leaves the doghouse gilead the greyhound leaves the doghouse jul   at  pm et on seeking alpha how astrazeneca failed not once — but twice — in cancer drugs astrazeneca azn not only failed in a lung cancer trial — which had the side effect of sending rival bristolmyers squibb bmy spiraling — but its partnership with dows merck mrk appears to be an admission of defeat in the initial immunooncology race shares of astrazeneca and bristolmyers sold off in droves early thursday on the stock market today astrazeneca took a pitfall to a fivemonth low down  near  bristol too jul   at  pm et on investors business daily key takeaways from lillys lly q call baricitinib cancer pipeline why were lillys lly shares down despite the company delivering a quotbeat and raisequot quarter jul   at  am et on zackscom biotech stock roundup amgen biogen top q estimates update on incyte ra drug earnings season kicked off on a positive note for biotech stocks with big players like amgen amgn and biogen reporting better than expected results jul   at  am et on zackscom eli lilly tumbles on arthritis drug delay a delay in getting its rheumatoid arthritis drug to market by at least  months sent eli lilly lly shares lower tuesday as the drug giant reported secondquarter earnings ibddisplayvideo id width floatleft autostarttrueon the stock market today lilly toppled  to close at  shares had been in a buy zone at mondays close after breaking out of a cupwithhandle at an  buy point lillys partner on the arthritis jul   at  pm et on investors business daily biotech bonanza the next leg up biotech bonanza the next leg up jul   at  pm et on seeking alpha lilly lly q earnings top baricitinib refiling delayed eli lilly and company lly beat estimates for both sales and earnings in q and upped its  outlook however it said the nda resubmission for baricitinib will not occur this year which hurt shares jul   at  am et on zackscom eli lilly tumbles on arthritis drug delay light q sales a delay in getting its rheumatoid arthritis drug to market by at least  months sent eli lilly lly shares lower tuesday as the drug giant reported secondquarter earnings ibddisplayvideo id width floatleft autostarttruein afternoon trades on the stock market today lilly toppled  near  shares had been in a buy zone at mondays close after breaking out of a cupwithhandle at an  buy point lillys partner on jul   at  pm et on investors business daily credit suisse lowers incyte price target to  on extended timeline for baricitinib credit suisse lowers incyte price target to  on extended timeline for baricitinib jul   at  pm et on seeking alpha refiling of us marketing application for arthritis med baricitinib at least  months away lilly down  incyte down  premarket refiling of us marketing application for arthritis med baricitinib at least  months away lilly down  incyte down  premarket jul   at  am et on seeking alpha  things in biotech you should learn today july    things in biotech you should learn today july   jul   at  am et on seeking alpha  reasons incyte is a better growth stock than exelixis  and  reason it isnt jul   at  pm et on motley fool  hottest biotech stocks of   are they still buys now jul   at  pm et on motley fool incyte launches latestage study assessing jak inhibitor itacitinib in in gvhd incyte launches latestage study assessing jak inhibitor itacitinib in in gvhd jul   at  am et on seeking alpha fdas flashing green light boosts novel drug approvals fdas flashing green light boosts novel drug approvals jul   at  pm et on seeking alpha keytruda expected to drive merck’s longterm revenue growth eli lilly lly and merck mrk together conducted the keynote trial for evaluation of the combination regimen in patients with nsclc jul   at  pm et on marketrealistcom incyte sees upgrade from vetr crowd incyte sees upgrade from vetr crowd jul   at  am et on benzingacom  reasons gilead will not acquire incyte  reasons gilead will not acquire incyte jul   at  pm et on seeking alpha the best and worstperforming stocks of last decade the best and worstperforming stocks of last decade jul   at  am et on gurufocuscom lilly and incyte provide update on baricitinib lilly and incyte provide update on baricitinib jul   at  am et on pr newswire  prf incyte announces first patient treated in phase  clinical trial of itacitinib for acute graftversushost disease incyte announces first patient treated in phase  clinical trial of itacitinib for acute graftversushost disease jul   at  am et on businesswire  bzx merus announces first quarter  financial results and midyear operating results merus announces first quarter  financial results and midyear operating results jul   at  pm et on globenewswire merus announces first quarter  financial results and midyear operating results merus announces first quarter  financial results and midyear operating results jul   at  pm et on globe newswire incyte to report second quarter financial results incyte to report second quarter financial results jul   at  am et on businesswire  bzx japan ministry of health labor and welfare mhlw grants marketing approval for olumiant® baricitinib for the treatment of rheumatoid arthritis japan ministry of health labor and welfare mhlw grants marketing approval for olumiant® baricitinib for the treatment of rheumatoid arthritis jul   at  am et on pr newswire  prf todays research reports on stocks to watch amgen and incyte todays research reports on stocks to watch amgen and incyte jun   at  am et on accesswire new safety and longterm efficacy data from baricitinib clinical trials in patients with moderatetosevere rheumatoid arthritis presented at eular  new safety and longterm efficacy data from baricitinib clinical trials in patients with moderatetosevere rheumatoid arthritis presented at eular  jun   at  am et on pr newswire  prf glycomimetics appoints boston biomedicalceo patricia s andrews to its board of directors glycomimetics appoints boston biomedicalceo patricia s andrews to its board of directors jun   at  am et on businesswire  bzx incyte to present at upcoming investor conferences incyte to present at upcoming investor conferences jun   at  pm et on businesswire  bzx corporate news blog  incyte and merck release phase clinical trial data for epacadostat in combination with keytrudar for treatment of nsclc corporate news blog  incyte and merck release phase clinical trial data for epacadostat in combination with keytrudar for treatment of nsclc jun   at  am et on accesswire todays research reports on stocks to watch juno therapeutics and incyte corporation todays research reports on stocks to watch juno therapeutics and incyte corporation jun   at  am et on accesswire incyte analyst and investor event to highlight clinical data presentations from asco  incyte analyst and investor event to highlight clinical data presentations from asco  jun   at  am et on businesswire  bzx clinical trial data for combination of epacadostat and opdivo® nivolumab demonstrate durable clinical responses in patients with melanoma and head and neck cancer clinical trial data for combination of epacadostat and opdivo® nivolumab demonstrate durable clinical responses in patients with melanoma and head and neck cancer jun   at  am et on businesswire  bzx updated data from echo trial of incyte’s epacadostat in combination with merck’s keytruda® pembrolizumab demonstrate clinical activity across multiple tumor types updated data from echo trial of incyte’s epacadostat in combination with merck’s keytruda® pembrolizumab demonstrate clinical activity across multiple tumor types jun   at  am et on businesswire  bzx combination of epacadostat plus keytruda® pembrolizumab demonstrates activity in clinical trial of patients with advanced nonsmall cell lung cancer nsclc combination of epacadostat plus keytruda® pembrolizumab demonstrates activity in clinical trial of patients with advanced nonsmall cell lung cancer nsclc jun   at  am et on businesswire  bzx combination of incyte’s epacadostat plus merck’s keytruda® pembrolizumab demonstrates activity in clinical trial of patients with advanced nonsmall cell lung cancer nsclc combination of incyte’s epacadostat plus merck’s keytruda® pembrolizumab demonstrates activity in clinical trial of patients with advanced nonsmall cell lung cancer nsclc jun   at  am et on businesswire  bzx blog coverage amgen announces new data from the fourier trial blog coverage amgen announces new data from the fourier trial may   at  am et on accesswire incyte to present at upcoming investor conferences incyte to present at upcoming investor conferences may   at  pm et on businesswire  bzx first data from combination of epacadostat with opdivo® nivolumab will be highlighted at asco  first data from combination of epacadostat with opdivo® nivolumab will be highlighted at asco  may   at  pm et on businesswire  bzx incyte corp incyte corp is a biopharmaceutical company which focuses on the discovery development development formulation manufacturing and commercialization of proprietary therapeutics to treat serious unmet medical needs primarily in oncology its product jakafi a jak and jak inhibitor is currently approved in the us for the treatment of intermediate or highrisk myelofibrosis and is in development as a potential treatment for other cancers the companywas founded by roy a whitfield in april  and is headquartered in wilmington de see full profile analyst ratings sell under hold over buy number of ratings  full ratings incyte sees upgrade from vetr crowd jul   at  am et on benzingacom how did abbvie stock fare in q jul   at  pm et on marketrealistcom  takeaways from mondays asco meetings puma biotech incyte celgene jun   at  pm et on benzingacom competitors name chg  market cap amgen inc  b geron corp  m celgene corp  b aveo pharmaceuticals inc  m novartis ag adr  b competitor data provided by partner content trending tickers powered by dvax  s  ssti  tsla  chtr  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience stocks index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest abreakingelon musk details tesla model  pricing range atesla standard model  will cost  longrange model will cost  pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stockscountryunited states index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest abreakingelon musk details tesla model  pricing range atesla standard model  will cost  longrange model will cost  pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  global incyte corporation product pipeline review   analysis technologies  forecasts report  research and markets  business wire global incyte corporation product pipeline review   analysis technologies  forecasts report  research and markets june    pm eastern daylight time dublinbusiness wireresearch and markets has announced the addition of the incyte corporation  product pipeline review   company profile to their offering the report incyte corporation  product pipeline review   provides an overview of the incyte corporations pharmaceutical research and development focus the report provides comprehensive information on the therapeutics under development by incyte corporation complete with analysis by stage of development drug target mechanism of action moa route of administration roa and molecule type the report also covers the descriptive pharmacological action of the therapeutics its complete research and development history and the dormant and discontinued projects the report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from proprietary databases companyuniversity websites clinical trial registries conferences sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information additionally various dynamic tracking processes ensure that the most recent developments are captured on a real time basis scope the report provides a snapshot of the pipeline therapeutic landscape of incyte corporation the report provides overview of incyte corporation including its business description key facts and locations and subsidiaries the report features descriptive drug profiles for the pipeline products which includes product description descriptive moa rd brief licensing and collaboration details  other developmental activities the report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages the report assesses incyte corporations pipeline therapeutics based on drug target mechanism of action moa route of administration roa and molecule type the report features incyte corporations outlicensed and partnered product portfolio and summarizes its dormant and discontinued projects for more information visit httpwwwresearchandmarketscomresearchrjwincyte contacts research and marketslaura wood senior managerpressresearchandmarketscomfor est office hours call for uscan toll free call for gmt office hours call us fax fax outside us sector company reports contacts research and marketslaura wood senior managerpressresearchandmarketscomfor est office hours call for uscan toll free call for gmt office hours call us fax fax outside us sector company reports search advanced news search advanced news search log in sign up incy stock price  incyte corp stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  col  lyb  fls  mo  sbux  gt  latest newsall times eastern a breaking elon musk details tesla model  pricing range a tesla standard model  will cost  longrange model will cost   updated wall street isn’t ready for a point tumble in the dow industrials  barrons buzz robo  facebook and twitter trading on news  a wild week in washington  updated the dark side of cruises  trump to police dont be too nice  updated the highest paid athletes in the world in one chart  updated oj simpson made over  while in prison and won’t have to give any of it to the goldman family  updated here are  coworkers you should avoid like the plague — especially in meetings to be replaced home investing quotes stocks united states incy overview compare quotes stock screener earnings calendar sectors nasdaq incy us nasdaq join td ameritrade find a broker incyte corp watchlist createincyalert after hours last updated jul    pm edt delayed quote     after hours volume k close chg chg     advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  m open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap b shares outstanding m public float m beta  rev per employee m pe ratio na eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume m performance  day   month   month  ytd   year  recent news marketwatch other dow jones eli lilly beats profit and sales expectations nda for ra treatment to be delayed eli lilly  co reported a secondquarter net profit that rose to  billion or  cents a share from  million or  cents a share in the same period a year ago excluding nonrecurring items adjusted eps was  beating the factset consensus of  revenue rose  to  billion above the factset consensus of  billion as strong growth in new pharmaceutical products helped offset weakness in animal health for  the drug giant expects adjusted eps of  to  surrounding the factset consensus of  while the revenue outlook was raised to  billion to  billion from  billion to  billion separately lilly and incyte corp said a resubmission for the new drug application for a treatment of rheumatoid arthritis will be delayed beyond  as the fda has indicated a new clinical study is necessary lillys stock was indicated slightly lower in premarket trade while incytes stock tumbled  year to date lilly shares have rallied  while the sp  has gained  jul   at  am et by tomi kilgore healthcare fund manager with  gain this year sees good times ahead as fda becomes ‘more accommodating’ jul   at  am et by philip van doorn scared of tech stocks healthcare shares are cheaper — and rallying jul   at  am et by philip van doorn wall street really hates giving any stock a ‘sell’ rating jun   at  am et by philip van doorn five reasons you have to buy biotech stocks now jun   at  pm et by michael brush three mustown cancer stocks for your biotechnology portfolio jun   at  pm et by michael brush cancer drug prices could double or triple thanks to this popular but unproven drug trend jun   at  pm et by emma court  big winners in the sp  this earnings season may   at  am et by philip van doorn stocks close higher as tech economic data power rebound may   at  pm et by barbara kollmeyer opinion what to do when your biotechnology stock gets hit by takeover rumors may   at  pm et by michael brush eli lilly beat profit views but cut outlook apr   at  am et stock market ends session slide as bank shares rally apr   at  pm et by wallace witkowski incyte stock price target cut to  from  at instinet apr   at  am et by tomi kilgore incyte stock price target cut to  from  at bmo capital apr   at  am et by tomi kilgore eli lilly and incyte stock drops after fda fails to approve rheumatoid arthritis drug apr   at  am et by emma court eli lilly stock drops  after fda failed to approve rheumatoid arthritis drug apr   at  am et by emma court incyte corp stock drops  after fda failed to approve rheumatoid arthritis drug apr   at  am et by emma court eli lilly and incyte fda letter says fda is unable to approve nda application in current form apr   at  am et by tomi kilgore eli lilly incyte receive complete response letter from fda apr   at  am et by tomi kilgore newlink genetics corp stock drops  on midstage results for melanoma drug apr   at  am et by emma court us stocks slide as oil slump hits energy sector us stock indexes retreated as oil prices slipped to their lowest levels since september pressuring the shares of energy companies jun   at  pm et on the wall street journal did gilead cut buybacks for acquisition gilead’s stock repurchases in the first quarter were half of the fourth quarter’s it may be eying incyte or biomarin may   at  am et on barrons online eli lilly working to cut costs apr   at  am et on the wall street journal stocks to watch moneygram eli lilly incyte apr   at  am et on the wall street journal fda rejects eli lilly and incyte rheumatoidarthritis drug apr   at  pm et on the wall street journal surprise fda rejection will sting this biotech apr   at  pm et on the wall street journal incyte why this biotech beauty can stay hot apr   at  pm et on barrons your cancer drugs may soon be discovered in china apr   at  am et on the wall street journal tech stocks that sit in the sweet spot mar   at  pm et on barrons race tightens for next wave of cancer drugs mar   at  am et on the wall street journal biotech executives sign letter against immigration order feb   at  pm et on the wall street journal more volatility ahead for biotechnology sector feb   at  pm et on the wall street journal drug pricing may linger over biotech in  jan   at  pm et on barrons smaller biotech buyout targets after medivation aug   at  am et on barrons incyte a biotech acquisition target jul   at  am et on barrons biotech labs birth new drugs—and new fortunes jun   at  pm et on the wall street journal bristolmyers to buy autoimmune disease treatment developer padlock mar   at  am et on the wall street journal agenus stock could surge to  mar   at  am et on barrons gilead way oversold as investors flee biotech feb   at  am et on barrons incyte reports profit but scraps trials involving cancer drug feb   at  am et on the wall street journal recent news other news press releases  things in biotech you should learn today july    things in biotech you should learn today july   jul   at  am et on seeking alpha gilead the greyhound leaves the doghouse gilead the greyhound leaves the doghouse jul   at  pm et on seeking alpha how astrazeneca failed not once — but twice — in cancer drugs astrazeneca azn not only failed in a lung cancer trial — which had the side effect of sending rival bristolmyers squibb bmy spiraling — but its partnership with dows merck mrk appears to be an admission of defeat in the initial immunooncology race shares of astrazeneca and bristolmyers sold off in droves early thursday on the stock market today astrazeneca took a pitfall to a fivemonth low down  near  bristol too jul   at  pm et on investors business daily key takeaways from lillys lly q call baricitinib cancer pipeline why were lillys lly shares down despite the company delivering a quotbeat and raisequot quarter jul   at  am et on zackscom biotech stock roundup amgen biogen top q estimates update on incyte ra drug earnings season kicked off on a positive note for biotech stocks with big players like amgen amgn and biogen reporting better than expected results jul   at  am et on zackscom eli lilly tumbles on arthritis drug delay a delay in getting its rheumatoid arthritis drug to market by at least  months sent eli lilly lly shares lower tuesday as the drug giant reported secondquarter earnings ibddisplayvideo id width floatleft autostarttrueon the stock market today lilly toppled  to close at  shares had been in a buy zone at mondays close after breaking out of a cupwithhandle at an  buy point lillys partner on the arthritis jul   at  pm et on investors business daily biotech bonanza the next leg up biotech bonanza the next leg up jul   at  pm et on seeking alpha lilly lly q earnings top baricitinib refiling delayed eli lilly and company lly beat estimates for both sales and earnings in q and upped its  outlook however it said the nda resubmission for baricitinib will not occur this year which hurt shares jul   at  am et on zackscom eli lilly tumbles on arthritis drug delay light q sales a delay in getting its rheumatoid arthritis drug to market by at least  months sent eli lilly lly shares lower tuesday as the drug giant reported secondquarter earnings ibddisplayvideo id width floatleft autostarttruein afternoon trades on the stock market today lilly toppled  near  shares had been in a buy zone at mondays close after breaking out of a cupwithhandle at an  buy point lillys partner on jul   at  pm et on investors business daily credit suisse lowers incyte price target to  on extended timeline for baricitinib credit suisse lowers incyte price target to  on extended timeline for baricitinib jul   at  pm et on seeking alpha refiling of us marketing application for arthritis med baricitinib at least  months away lilly down  incyte down  premarket refiling of us marketing application for arthritis med baricitinib at least  months away lilly down  incyte down  premarket jul   at  am et on seeking alpha  things in biotech you should learn today july    things in biotech you should learn today july   jul   at  am et on seeking alpha  reasons incyte is a better growth stock than exelixis  and  reason it isnt jul   at  pm et on motley fool  hottest biotech stocks of   are they still buys now jul   at  pm et on motley fool incyte launches latestage study assessing jak inhibitor itacitinib in in gvhd incyte launches latestage study assessing jak inhibitor itacitinib in in gvhd jul   at  am et on seeking alpha fdas flashing green light boosts novel drug approvals fdas flashing green light boosts novel drug approvals jul   at  pm et on seeking alpha keytruda expected to drive merck’s longterm revenue growth eli lilly lly and merck mrk together conducted the keynote trial for evaluation of the combination regimen in patients with nsclc jul   at  pm et on marketrealistcom incyte sees upgrade from vetr crowd incyte sees upgrade from vetr crowd jul   at  am et on benzingacom  reasons gilead will not acquire incyte  reasons gilead will not acquire incyte jul   at  pm et on seeking alpha the best and worstperforming stocks of last decade the best and worstperforming stocks of last decade jul   at  am et on gurufocuscom lilly and incyte provide update on baricitinib lilly and incyte provide update on baricitinib jul   at  am et on pr newswire  prf incyte announces first patient treated in phase  clinical trial of itacitinib for acute graftversushost disease incyte announces first patient treated in phase  clinical trial of itacitinib for acute graftversushost disease jul   at  am et on businesswire  bzx merus announces first quarter  financial results and midyear operating results merus announces first quarter  financial results and midyear operating results jul   at  pm et on globenewswire merus announces first quarter  financial results and midyear operating results merus announces first quarter  financial results and midyear operating results jul   at  pm et on globe newswire incyte to report second quarter financial results incyte to report second quarter financial results jul   at  am et on businesswire  bzx japan ministry of health labor and welfare mhlw grants marketing approval for olumiant® baricitinib for the treatment of rheumatoid arthritis japan ministry of health labor and welfare mhlw grants marketing approval for olumiant® baricitinib for the treatment of rheumatoid arthritis jul   at  am et on pr newswire  prf todays research reports on stocks to watch amgen and incyte todays research reports on stocks to watch amgen and incyte jun   at  am et on accesswire new safety and longterm efficacy data from baricitinib clinical trials in patients with moderatetosevere rheumatoid arthritis presented at eular  new safety and longterm efficacy data from baricitinib clinical trials in patients with moderatetosevere rheumatoid arthritis presented at eular  jun   at  am et on pr newswire  prf glycomimetics appoints boston biomedicalceo patricia s andrews to its board of directors glycomimetics appoints boston biomedicalceo patricia s andrews to its board of directors jun   at  am et on businesswire  bzx incyte to present at upcoming investor conferences incyte to present at upcoming investor conferences jun   at  pm et on businesswire  bzx corporate news blog  incyte and merck release phase clinical trial data for epacadostat in combination with keytrudar for treatment of nsclc corporate news blog  incyte and merck release phase clinical trial data for epacadostat in combination with keytrudar for treatment of nsclc jun   at  am et on accesswire todays research reports on stocks to watch juno therapeutics and incyte corporation todays research reports on stocks to watch juno therapeutics and incyte corporation jun   at  am et on accesswire incyte analyst and investor event to highlight clinical data presentations from asco  incyte analyst and investor event to highlight clinical data presentations from asco  jun   at  am et on businesswire  bzx clinical trial data for combination of epacadostat and opdivo® nivolumab demonstrate durable clinical responses in patients with melanoma and head and neck cancer clinical trial data for combination of epacadostat and opdivo® nivolumab demonstrate durable clinical responses in patients with melanoma and head and neck cancer jun   at  am et on businesswire  bzx updated data from echo trial of incyte’s epacadostat in combination with merck’s keytruda® pembrolizumab demonstrate clinical activity across multiple tumor types updated data from echo trial of incyte’s epacadostat in combination with merck’s keytruda® pembrolizumab demonstrate clinical activity across multiple tumor types jun   at  am et on businesswire  bzx combination of epacadostat plus keytruda® pembrolizumab demonstrates activity in clinical trial of patients with advanced nonsmall cell lung cancer nsclc combination of epacadostat plus keytruda® pembrolizumab demonstrates activity in clinical trial of patients with advanced nonsmall cell lung cancer nsclc jun   at  am et on businesswire  bzx combination of incyte’s epacadostat plus merck’s keytruda® pembrolizumab demonstrates activity in clinical trial of patients with advanced nonsmall cell lung cancer nsclc combination of incyte’s epacadostat plus merck’s keytruda® pembrolizumab demonstrates activity in clinical trial of patients with advanced nonsmall cell lung cancer nsclc jun   at  am et on businesswire  bzx blog coverage amgen announces new data from the fourier trial blog coverage amgen announces new data from the fourier trial may   at  am et on accesswire incyte to present at upcoming investor conferences incyte to present at upcoming investor conferences may   at  pm et on businesswire  bzx first data from combination of epacadostat with opdivo® nivolumab will be highlighted at asco  first data from combination of epacadostat with opdivo® nivolumab will be highlighted at asco  may   at  pm et on businesswire  bzx incyte corp incyte corp is a biopharmaceutical company which focuses on the discovery development development formulation manufacturing and commercialization of proprietary therapeutics to treat serious unmet medical needs primarily in oncology its product jakafi a jak and jak inhibitor is currently approved in the us for the treatment of intermediate or highrisk myelofibrosis and is in development as a potential treatment for other cancers the companywas founded by roy a whitfield in april  and is headquartered in wilmington de see full profile analyst ratings sell under hold over buy number of ratings  full ratings incyte sees upgrade from vetr crowd jul   at  am et on benzingacom how did abbvie stock fare in q jul   at  pm et on marketrealistcom  takeaways from mondays asco meetings puma biotech incyte celgene jun   at  pm et on benzingacom competitors name chg  market cap amgen inc  b geron corp  m celgene corp  b aveo pharmaceuticals inc  m novartis ag adr  b competitor data provided by partner content trending tickers powered by dvax  s  ssti  tsla  chtr  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience data dumps    freebase api deprecated    google developers freebase api deprecated all products sign in send feedback hey there are you maybe looking for firebase instead data dumps the freebase api will be completely shutdown on aug   this page provides access to the last available data dump read more data dumps are a downloadable version of the data in freebase they constitute a snapshot of the data stored in freebase and the schema that structures it and are provided under the same ccby license the freebasewikidata mappings are provided under the cc license freebase triples freebase deleted triples freebasewikidata mappings license citing freebase triples this dataset contains every fact currently in freebase total triples  billion updated weekly data format ntriples rdf license ccby  gb gzip gb uncompressed download the rdf data is serialized using the ntriples format encoded as utf text and compressed with gzip rdf httprdffreebasecomnsgvjzynm httprdffreebasecomnsmeasurementunitdatedpercentagedate httpwwwworgxmlschemagyearmonth  httprdffreebasecomnsgvjzynm httprdffreebasecomnsmeasurementunitdatedpercentagesource httprdffreebasecomnsgxgfm  httprdffreebasecomnsgvjzynm httprdffreebasecomnstypeobjecttype httprdffreebasecomnsmeasurementunitdatedpercentage  httprdffreebasecomnsgvjzynm httprdffreebasecomnsmeasurementunitdatedpercentagerate   httprdffreebasecomnsgvjzynm httpwwwworgrdfsyntaxnstype httprdffreebasecomnsmeasurementunitdatedpercentage  if youre writing your own code to parse the rdf dumps its often more efficient to read directly from gzip file rather than extracting the data first and then processing the uncompressed data subject predicate object  note in freebase objects have mids that look like mrkqx in rdf those mids become mrkqx likewise freebase schema like commontopic are written as commontopic the subject is the id of a freebase object it can be a freebase mid ex mrkqx for topics and cvts or a humanreadable id ex commontopic for schema the predicate is always a humanreadable id for a freebase property or a property from a standard rdf vocabulary like rdfs freebase foreign key namespaces are also used as predicates to make it easier to look up keys by namespace the object field may contain a freebase mid for an object or a humanreadable id for schema from freebase or other rdf vocabularies it may also include literal values like strings booleans and numeric values topic descriptions often contain newlines in order to make each triple fit on one line we have escaped newlines with n freebase deleted triples we also provide a dump of triples that have been deleted from freebase over time this is a onetime dump through march  in the future we might consider providing periodic updates of recently deleted triples but at the moment we have no specific timeframe for doing so and are only providing this onetime dump the dump is distributed as a targz file gb compressed gb uncompressed it contains  deleted triples in  files there is no particular meaning to the individual files it is just easier to manipulate several smaller files than one huge file thanks to chun how tan and john giannandrea for making this data release possible total triples  million updated june   data format csv license ccby  gb gzip gb uncompressed download the data format is essentially csv with one important caveat the object field may contain any characters including commas as well as any other reasonable delimiters you could think of however all the other fields are guaranteed not to contain commas so the data can still be parsed unambiguously the columns in the dataset are defined as creationtimestamp unix epoch time in milliseconds creator deletiontimestamp unix epoch time in milliseconds deletor subject mid predicate mid object midliteral languagecode csv usermwclwikipediaenusermwclwikipediaenmrtypeobjectkeywikipediaenben usermwclmusicbrainzuserturtlewaxbotmnncpzmusicrecordingartistmvbfmen usermwclimagesusergardeningbotmwmcommonimagesizemklyen usermwclmusicbrainzusermbzpipelinemergebotmfvvltypeobjecttypecommontopicen usermwclimagesusergardeningbotmxsczcommonlicensedobjectlicensemxben usercontentadministratorusergardeningbotmgkbytypeobjecttypetypecontenten usermwclimagesusergardeningbotmhcommontopicimagemcsen usermwclchefmozuserdeletebotmzcztypeobjectnamela casa rosa mexican restauranten freebasewikidata mappings the data has been created based on the wikidatadump of october   and contains only those links that have at least two common wikipedialinks and not a single disagreeing wikipedialink furthermore the lines are sorted by the number of common wikipedialinks although in turtle this does not really matter total triples m updated october   data format ntriples rdf license cc  mb gzip mb uncompressed download the rdf data is serialized using the ntriples format encoded as utf text and compressed with gzip rdf httprdffreebasecomnsmj httpwwwworgowlsameas httpwwwwikidataorgentityq  httprdffreebasecomnsmnrg httpwwwworgowlsameas httpwwwwikidataorgentityq  httprdffreebasecomnsmjgd httpwwwworgowlsameas httpwwwwikidataorgentityq  httprdffreebasecomnsmd httpwwwworgowlsameas httpwwwwikidataorgentityq  httprdffreebasecomnsmgd httpwwwworgowlsameas httpwwwwikidataorgentityq  license freebase data dumps are provided free of charge for any purpose with regular updates by google they are distributed like freebase itself under the creative commons attribution aka ccby and use is subject to the terms of service the freebasewikidata id mappings are provided under cc and can be used without restrictions citing if youd like to cite these data dumps in a publication you may use google freebase data dumps httpsdevelopersgooglecomfreebasedata month day year or as bibtex bibtex misc x please select a profession that best describes you individual investor business executive wirehouse financial advisor ria institutional investor for market realist updates enter your email below submit thank you follow us on twitter flashratings  contact us facebook autocomplete demo post a rating  month price target   trending sign up log in contact flashratings your emotional state excited confused worried upset panicked angry flashratings  about us facebook autocomplete demo post a rating  month price target   trending sign up log in flashratings  all research for my stocks the most comprehensive equity research coverage available online never miss a single piece of research upgrade downgrade or target price change by any analyst firm on any stock equity research by professional analysts  especially their rationales more than their forecasts  contains far more interesting and important information about the actual fundamentals of the traded companies than can be gathered from conventional news reports our mission is to unlock access to valuable research on stocks for all retail investors professionals institutions take advantage of our costeffective subscriptions to have flashratingss comprehensive realtime feed delivered into your intranet and trading floor platforms institutional subscriptions websites become a content licensing partner and display flashratingss popular news feed on your website content licensing advertisers advertise with us and have flashratings readers with attractive demographics take advantage of your products advertising incyte incyte  twitter skip to content home home home current page moments moments moments current page search query search twitter saved searches remove in this conversation verified accountprotected tweets  suggested users verified accountprotected tweets  verified accountprotected tweets  language english bahasa indonesia bahasa melayu català čeština dansk deutsch english uk español filipino français hrvatski italiano magyar nederlands norsk polski português română slovenčina suomi svenska tiếng việt türkçe ελληνικά български език русский српски українська мова עִבְרִית العربية فارسی मराठी हिन्दी বাংলা ગુજરાતી தமிழ் ಕನ್ನಡ ภาษาไทย 한국어    have an account log in have an account remember me · forgot password new to twitter sign up incyte incyte tweets tweets current page  following following  followers followers  likes likes    more likes unmute incyte mute incyte follow following unfollow blocked unblock pending cancel incyte incyte incyte’s official twitter handle rigorous science is at the core of everything we do us residents only see our community guidelines httpbitlyxgpcln  wilmington de incytecom joined october   photos and videos photos and videos tweets tweets tweets current page tweets  replies media you blocked incyte are you sure you want to view these tweets viewing tweets wont unblock incyte yes view profile close incyte followed incyte‏ incyte h hours ago more copy link to tweet embed tweet sciencespotlight we are investigating antigitr agonist antibodies  their role in antitumor immunity httpbitlynfmgbg pictwittercomrzsitqyjq  replies  retweet  like reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo incyte‏ incyte jul  more copy link to tweet embed tweet we are committed to science we are committed to patients we are committed to the global healthcare communityhttpscardstwittercomcardscebicgubc …  replies  retweets  likes reply retweet retweeted like liked thanks twitter will use this to make your timeline better undo incyte‏ incyte jul  more copy link to tweet embed tweet according to the mpn landmark survey mpn patients personal and work life can be impacted by their condition httpbitlycdej pictwittercomotawwtazqs  replies  retweets  like reply retweet retweeted like  liked  thanks twitter will use this to make your timeline better undo incyte‏ incyte jul  more copy link to tweet embed tweet looking for educational  awareness resources for mpns check out voicesofmpn today to learn more ff  replies  retweets  likes reply retweet retweeted like liked thanks twitter will use this to make your timeline better undo incyte‏ incyte jul  more copy link to tweet embed tweet breaking first patient treated in pivotal ph  clinical trial for acute graftversushost diseasehttpscardstwittercomcardscebickbo …  replies  retweets  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo incyte‏ incyte jul  more copy link to tweet embed tweet incyte retweeted global delaware our ceo herve hoppenot highlights our discovery and innovation in delaware delawareglobalhttpstwittercomdelawareglobalstatus … incyte added global delawareverified account delawareglobal delaware provides the ideal environment for global pharmaceutical companies incyte innovation globalde netde httpbufflyvbdyc   replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo incyte‏ incyte jul  more copy link to tweet embed tweet we continually modify our discovery resourcing efforts as we aim to ensure the most efficient  datarich executionhttpscardstwittercomcardscebicgue …  replies  retweets  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo incyte‏ incyte jul  more copy link to tweet embed tweet biggest obstacles to diagnosing rare diseases like mpns lack of awareness  info learn more at httpwwwvoicesofmpncom pictwittercomlubvhiqqz  replies  retweets  likes reply retweet retweeted like liked thanks twitter will use this to make your timeline better undo incyte‏ incyte jul  more copy link to tweet embed tweet sciencespotlight were investigating inhibitors that target the bet brd proteins find out more httpbitlynfmgbg pictwittercomkfrwutri  replies  retweet  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo incyte‏ incyte jul  more copy link to tweet embed tweet as we expand our discovery efforts  aim to grow our portfolio our team remains our greatest strengthhttpscardstwittercomcardscebicipco …  reply  retweets  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo incyte‏ incyte jul  more copy link to tweet embed tweet our discovery approach integrates target selection portfolio fit compound quality  pharmacodynamic optimizationhttpscardstwittercomcardscebicimvz …  replies  retweets  likes reply retweet retweeted like liked thanks twitter will use this to make your timeline better undo incyte‏ incyte jul  more copy link to tweet embed tweet living with an mpn it counts to know you’re not alone get support and info at httpwwwvoicesofmpncom  connectmpnspictwittercomlvgtoaszw  replies  retweet  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo incyte‏ incyte jul  more copy link to tweet embed tweet outside of our labs serving our community is an integral part of our culture  who we are as a companyhttpscardstwittercomcardscebicimvm …  replies  retweet  likes reply retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo incyte‏ incyte jul  more copy link to tweet embed tweet are you or someone you know living with an mpn be sure to follow the recently launched voicesofmpn for educational resources  more  replies  retweets  likes reply retweet retweeted like liked thanks twitter will use this to make your timeline better undo incyte‏ incyte jul  more copy link to tweet embed tweet the voices of mpn patient education session is coming to providence ri join us on thurs  for the free eventhttpscardstwittercomcardscebicguw …  replies  retweets  likes reply retweet retweeted like liked thanks twitter will use this to make your timeline better undo incyte‏ incyte jul  more copy link to tweet embed tweet since  our scientists have strived to create innovative medicines for patients through rigorous sciencehttpscardstwittercomcardscebicgue …  replies  retweets  likes reply  retweet  retweeted  like  liked  thanks twitter will use this to make your timeline better undo incyte‏ incyte jul  more copy link to tweet embed tweet the origin of the word cancer as told by dr howard markel on nprhttpnprshgtzu   replies  retweets  like reply retweet retweeted like  liked  thanks twitter will use this to make your timeline better undo incyte‏ incyte jul  more copy link to tweet embed tweet wishing our us friends a happy fourthofjuly from all of us at incytepictwittercomujwmxbinpe  replies  retweets  likes reply retweet retweeted like  liked  thanks twitter will use this to make your timeline better undo incyte‏ incyte jul  more copy link to tweet embed tweet are you in the new haven ct area join us on tuesday  for a free voices of mpn patient education sessionhttpscardstwittercomcardscebicgtr …  replies  retweets  like reply retweet retweeted like  liked  thanks twitter will use this to make your timeline better undo incyte‏ incyte jun  more copy link to tweet embed tweet we thrive on one anothers differences  strengths to achieve one goal deliver innovative medicines for patientshttpscardstwittercomcardscebicdw …  replies  retweets  likes reply retweet retweeted like  liked  thanks twitter will use this to make your timeline better undo incyte hasnt tweeted yet back to top ↑ loading seems to be taking a while twitter may be over capacity or experiencing a momentary hiccup try again or visit twitter status for more information new to twitter sign up now to get your own personalized timeline sign up you may also like · refresh false   twitter about help center terms privacy policy cookies ads info close choose a trend location dismiss close previous next close go to a persons profile saved searches remove in this conversation verified accountprotected tweets  suggested users verified accountprotected tweets  verified accountprotected tweets  close promote this tweet close block cancel block add a location to your tweets when you tweet with a location twitter stores that location you can switch location onoff before each tweet and always have the option to delete your location history learn more turn location on not now close share location results from send close your lists close create a new list list name description under  characters optional privacy public · anyone can follow this list private · only you can access this list save list close close copy link to tweet heres the url for this tweet copy it to easily share with friends close embed this tweet embed this video add this tweet to your website by copying the code below learn more add this video to your website by copying the code below learn more hmm there was a problem reaching the server try again include parent tweet include media by embedding twitter content in your website or app you are agreeing to the twitter developer agreement and developer policy preview close why youre seeing this ad close log in to twitter remember me · forgot password dont have an account sign up » close sign up for twitter not on twitter sign up tune into the things you care about and get updates as they happen sign up have an account log in » close twoway sending and receiving short codes country code for customers of united states  any canada  any united kingdom  vodafone orange  o brazil  nextel tim haiti  digicel voila ireland  vodafone o india  bharti airtel videocon reliance indonesia  axis  telkomsel indosat xl axiata italy  wind  vodafone » see sms short codes for other countries close confirmation close   close skip all welcome home this timeline is where you’ll spend most of your time getting instant updates about what matters to you tweets not working for you hover over the profile pic and click the following button to unfollow any account say a lot with a little when you see a tweet you love tap the heart — it lets the person who wrote it know you shared the love spread the word the fastest way to share someone else’s tweet with your followers is with a retweet tap the icon to send it instantly join the conversation add your thoughts about any tweet with a reply find a topic you’re passionate about and jump right in learn the latest get instant insight into what people are talking about now get more of what you love follow more accounts to get instant updates about topics you care about find whats happening see the latest conversations about any topic instantly never miss a moment catch up instantly on the best stories happening as they unfold back next next tweet from user facebook autocomplete demo post a rating  month price target   home trending sign up log in analyst ranking   name measured ratings sucess rate avg return  mizuho      credit suisse      jefferies      cantor fitzgerald      bank of america merrill lynch      jmp securities      goldman sachs      raymond james      fbr capital markets      william blair     creative commons — attributionsharealike  unported — cc bysa  skip to content menu help us build a vibrant collaborative global commons donate now creative commons creative commons license deed attributionsharealike  unported cc bysa  this is a humanreadable summary of and not a substitute for the license disclaimer you are free to share — copy and redistribute the material in any medium or format adapt — remix transform and build upon the material for any purpose even commercially the licensor cannot revoke these freedoms as long as you follow the license terms under the following terms attribution — you must give appropriate credit provide a link to the license and indicate if changes were made you may do so in any reasonable manner but not in any way that suggests the licensor endorses you or your use attribute this work sharealike — if you remix transform or build upon the material you must distribute your contributions under the same license as the original no additional restrictions — you may not apply legal terms or technological measures that legally restrict others from doing anything the license permits notices you do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation no warranties are given the license may not give you all of the permissions necessary for your intended use for example other rights such as publicity privacy or moral rights may limit how you use the material learn more about cc licensing or use the license for your own material this content is freely available under simple legal terms because of creative commons a nonprofit that survives on donations if you love this content and love that its free for everyone please consider a donation to support our work make a donation this page is available in the following languages castellano castellano españa català dansk deutsch english esperanto français galego hrvatski indonesia italiano latviski lietuvių melayu nederlands norsk polski português português br română slovenščina suomeksi svenska türkçe íslenska česky ελληνικά беларуская русский українська العربية پارسی     한국어 this content is freely available under simple legal terms because of creative commons a nonprofit that survives on donations if you love this content and love that its free for everyone please consider a donation to support our work when you share everyone wins contribute today to creative commons     disclaimer this deed highlights only some of the key features and terms of the actual license it is not a license and has no legal value you should carefully review all of the terms and conditions of the actual license before using the licensed material creative commons is not a law firm and does not provide legal services distributing displaying or linking to this deed or the license that it summarizes does not create a lawyerclient or any other relationship what does attribute this work mean the page you came from contained embedded licensing metadata including how the creator wishes to be attributed for reuse you can use the html here to cite the work doing so will also include metadata on your page so that others can find the original work as well the applicable mediation rules will be designated in the copyright notice published with the work or if none then in the request for mediation unless otherwise designated in a copyright notice attached to the work the uncitral arbitration rules apply to any arbitration more info if supplied you must provide the name of the creator and attribution parties a copyright notice a license notice a disclaimer notice and a link to the material cc licenses prior to version  also require you to provide the title of the material if supplied and may have other slight differences more info in  you must indicate if you modified the material and retain an indication of previous modifications in  and earlier license versions the indication of changes is only required if you create a derivative marking guide more info you may also use a license listed as compatible at httpscreativecommonsorgcompatiblelicenses more info a commercial use is one primarily intended for commercial advantage or monetary compensation more info merely changing the format never creates a derivative more info the license prohibits application of effective technological measures defined with reference to article  of the wipo copyright treaty more info the rights of users under exceptions and limitations such as fair use and fair dealing are not affected by the cc licenses more info you may need to get additional permissions before using the material as you intend more info pharmaceutical research  product development  incytecom pharmaceutical research  oncology product development  incytecom for patients for hcps for media contact us search who we are our commitment our leadership what we do discover develop deliver collaborate incyte involved join us our culture your career for investors investor overview press releases events  presentationsevents  presentations financial informationfinancial information stock information toggle navigation search who we are our commitment our leadership what we do discover develop deliver collaborate incyte involved join us our culture your career for investors investor overview press releases events  presentations financial information stock information for patients for hcps for media contact us home search results below youll see everything we could locate for your search of “”   page   pharmaceutical research  product development  incytecom pharmaceutical research  oncology product development  incytecom for patients for hcps for media contact us search who we are our commitment our leadership what we do discover develop deliver collaborate incyte involved join us our culture your career for investors investor overview press releases events  presentationsevents  presentations financial informationfinancial information stock information toggle navigation search who we are our commitment our leadership what we do discover develop deliver collaborate incyte involved join us our culture your career for investors investor overview press releases events  presentations financial information stock information for patients for hcps for media contact us home search results below youll see everything we could locate for your search of “”   page   incyte corporationnasdaqincy incyte corporation incy product news news  stocknewscom     follow us stocktwits twitter incyte corporation incy product news news incy – incyte and eli lilly announces the resubmission to the fda of the nda for baricitinib a oncedaily oral medication for the treatment of moderatetosevere rheumatoid arthritis will be delayed beyond  jul    am  by stocknewscom staff product news key facts surrounding this news item incy had a powr rating of b buy coming into today incy was  above its day moving average coming into today incy was  above its day moving average coming into today incy was  above its day moving average coming into today incy was  above its day moving average coming into today incy was  above its day moving average coming into today incy had returned  yeartodate leading up to today’s news versus a  return from the benchmark sp  during the same period more info about incyte corporation incy incyte corporation focuses on the discovery development and commercialization of proprietary therapeutics in oncology in the united states and internationally the company was founded in  and is based in wilmington delaware view our full incy ticker page with ratings news and more incy at a glance incy current powr rating™ overall powr rating™ incy current price   more incy ratings data and news incy price reaction the day of this event jul  incy closing price incy volume from avgleading up to this eventincy mo returnnaafter this eventincy day returnincy day return incy price chart more incyte corporation incy news view all eventdate symbol news detail start price end price change powr rating loading please wait view all incy news page generated in  seconds